Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish drug adherence guidelines for covered drugs under Medicare so as to achieve an adherence rate of 90%. The CMS must incorporate artificial intelligence and machine-learning technologies and promote generics and biosimilars when developing the guidance.
Introduced
Feb 7, 2025
Last Action
Feb 7, 2025
Session
119th Congress
Sponsors
1 primary · 0 co
Passage Probability
2% — Very Low
Introduced in House
Referred to the House Committee on Energy and Commerce.
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
2%
Estimate based on legislative signals
See what factors are driving this score — cosponsor support, bipartisan backing, committee progress, and more.
Upgrade to ProReferred to the House Committee on Energy and Commerce.